Chien-Yi Ho

426 total citations
10 papers, 337 citations indexed

About

Chien-Yi Ho is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chien-Yi Ho has authored 10 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chien-Yi Ho's work include DNA Repair Mechanisms (2 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Kidney Stones and Urolithiasis Treatments (2 papers). Chien-Yi Ho is often cited by papers focused on DNA Repair Mechanisms (2 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Kidney Stones and Urolithiasis Treatments (2 papers). Chien-Yi Ho collaborates with scholars based in Taiwan and United States. Chien-Yi Ho's co-authors include Sheng-Feng Hsu, Chun‐Hsu Yao, Yueh-Sheng Chen, Han-Chung Lee, Jia‐Horng Lin, Wei‐Chien Huang, Wen‐Chi Chen, Yu‐Cheng Chen, Ming-Tsung Lai and Fuu‐Jen Tsai and has published in prestigious journals such as International Journal of Molecular Sciences, BioMed Research International and Oncotarget.

In The Last Decade

Chien-Yi Ho

10 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chien-Yi Ho Taiwan 10 137 75 53 41 35 10 337
Xueman Zhou China 11 163 1.2× 15 0.2× 66 1.2× 122 3.0× 20 0.6× 31 431
Lara Milián Spain 12 124 0.9× 31 0.4× 106 2.0× 62 1.5× 110 3.1× 33 506
Sandra M. Ayuk South Africa 9 205 1.5× 17 0.2× 31 0.6× 133 3.2× 45 1.3× 12 655
Min Han China 13 226 1.6× 13 0.2× 35 0.7× 101 2.5× 20 0.6× 23 427
Liang Luo China 8 84 0.6× 65 0.9× 26 0.5× 38 0.9× 56 1.6× 35 398
Ruohan Yang China 15 194 1.4× 43 0.6× 44 0.8× 76 1.9× 36 1.0× 29 428
Mohammad Hadi Farjoo Iran 9 142 1.0× 16 0.2× 31 0.6× 54 1.3× 34 1.0× 13 367
Roberta Affatato Italy 10 118 0.9× 32 0.4× 41 0.8× 52 1.3× 44 1.3× 17 347
Jiangbo Nie China 9 146 1.1× 17 0.2× 29 0.5× 63 1.5× 45 1.3× 18 313
Weiyang Ying China 11 119 0.9× 60 0.8× 71 1.3× 48 1.2× 34 1.0× 15 334

Countries citing papers authored by Chien-Yi Ho

Since Specialization
Citations

This map shows the geographic impact of Chien-Yi Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien-Yi Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien-Yi Ho more than expected).

Fields of papers citing papers by Chien-Yi Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien-Yi Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien-Yi Ho. The network helps show where Chien-Yi Ho may publish in the future.

Co-authorship network of co-authors of Chien-Yi Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Chien-Yi Ho. A scholar is included among the top collaborators of Chien-Yi Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien-Yi Ho. Chien-Yi Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Ho, Chien-Yi, Chien‐Kuo Wang, Yun‐Ju Chen, et al.. (2019). Proteasome Inhibitors Suppress ErbB Family Expression through HSP90-Mediated Lysosomal Degradation. International Journal of Molecular Sciences. 20(19). 4812–4812. 10 indexed citations
3.
Liu, Liang‐Chih, Chia-Jui Yen, Yun‐Ju Chen, et al.. (2016). Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression. Oncotarget. 7(35). 56309–56323. 10 indexed citations
4.
Yen, Chia-Jui, Yun‐Ju Chen, Shu-Jun Chiu, et al.. (2015). miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin. Oncotarget. 6(28). 25962–25974. 31 indexed citations
5.
Hung, Chao-Ming, Wei‐Chien Huang, Chih‐Wen Lin, et al.. (2014). Hepatitis B Virus X Upregulates HuR Protein Level to Stabilize HER2 Expression in Hepatocellular Carcinoma Cells. BioMed Research International. 2014. 1–9. 27 indexed citations
6.
Hsia, Te‐Chun, et al.. (2012). Association of DNA double-strand break gene XRCC6 genotypes and lung cancer in Taiwan.. PubMed. 32(3). 1015–20. 15 indexed citations
7.
Tsai, Ming-Hsui, Yung-An Tsou, Liang-Chun Shih, et al.. (2012). The joint effect of smoking and hOGG1 genotype on oral cancer in Taiwan.. PubMed. 32(9). 3799–803. 15 indexed citations
9.
Ho, Chien-Yi, Sheng-Feng Hsu, Han-Chung Lee, et al.. (2007). Effects of Electrical Stimulation at Different Frequencies on Regeneration of Transected Peripheral Nerve. Neurorehabilitation and neural repair. 22(4). 367–373. 106 indexed citations
10.
Chen, Yu‐Cheng, et al.. (2007). Wu-Ling-San Formula Inhibits the Crystallization of Calcium OxalateIn Vitro. The American Journal of Chinese Medicine. 35(3). 533–541. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026